New scan could spot prostate cancer more accurately

NCT ID NCT05847166

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new radioactive imaging agent called PSMA-T4 to see if it can safely and accurately find prostate cancer tumors. About 80 men with prostate cancer will receive an injection of PSMA-T4 and then have a special scan (SPECT/CT) to detect cancer lesions. The goal is to improve diagnosis and treatment planning by comparing this new method with standard imaging techniques.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • 4. Wojskowy Szpital Kliniczny z Polikliniką SP ZOZ

    COMPLETED

    Wroclaw, Poland, 53-114, Poland

  • Centralny Szpital Kliniczny Uniwersytetu Medycznego

    RECRUITING

    Lodz, Poland, 92-216, Poland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Centrum Onkologii im. prof. F. Łukaszczyka

    RECRUITING

    Bydgoszcz, Poland, 85-796, Poland

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • GAMMED Centrum Diagnostyczno-Lecznicze

    RECRUITING

    Warsaw, Poland, 02-351, Poland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact